ONO-4538 Phase II (Rollover) Study (ONO-4538-98)
Phase 2
Recruiting
- Conditions
- Pan-Tumor
- Registration Number
- JPRN-jRCT2080225345
- Lead Sponsor
- ONO PHARMACEUTICAL CO., LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- recruiting
- Sex
- All
- Target Recruitment
- 59
Inclusion Criteria
1. Participant who is being treated with ONO-4538 as monotherapy or in Combination with Other Therapies in clinical trials
2. Participant who is eligible for ONO-4538 monotherapy or in combination with other therapies as per the clinical trials, and/or
investigator-assessed clinical benefit
Exclusion Criteria
1. Participant judged to be incapable of providing consent for reasons such as concurrent dementia
2. Participant judged by the investigator to be inappropriate as participants of this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety<br>Incidence of AEs
- Secondary Outcome Measures
Name Time Method